# Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers

> **NCT03504475** · PHASE1 · COMPLETED · sponsor: **Beijing Tongren Hospital** · enrollment: 53 (actual)

## Conditions studied

- Major Depressive Disorder
- Obsessive-Compulsive Disorder
- Panic Disorder
- Social Anxiety Disorder
- Generalized Anxiety Disorder

## Interventions

- **DRUG:** Paroxetine Hydrochloride Tablet 20 mg
- **DRUG:** Paxil® 20 mg

## Key facts

- **NCT ID:** NCT03504475
- **Lead sponsor:** Beijing Tongren Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-29
- **Primary completion:** 2018-04-24
- **Final completion:** 2018-06-16
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2018-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03504475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03504475, "Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03504475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*